Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol

Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol

The introduction of anti-amyloid therapies for Alzheimer’s disease (AD), such as lecanemab (Lequembi ®), which was recently approved in Korea, necessitates careful monitoring for amyloid-related imaging abnormalities (ARIA) using brain MRI. To optimize ARIA monitoring in Korean clinical settings,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jimin Kim, Eunhee Kim, Mina Park, Yun Jung Bae, Chong Hyun Suh, Sung-Hye You, Younghee Yim, Ho-Joon Lee, Jin Wook Choi, Se Won Oh, Won-Jin Moon
Format:	Article
Language:	English
Published:	The Korean Society of Radiology 2025-01-01
Series:	Journal of the Korean Society of Radiology
Subjects:	alzheimer’s disease amyloid-related imaging abnormalities anti-amyloid monoclonal antibodies magnetic resonance imaging monitoring
Online Access:	https://doi.org/10.3348/jksr.2024.0147
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
by: I. A. Mazerkina
Published: (2025-04-01)

Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
by: Byeong-Hyeon Kim, et al.
Published: (2025-01-01)

Two cases of Amyloid-Related Imaging Abnormalities (ARIA) following lecanemab treatment for alzheimer’s disease and a literature review
by: Yingte Wang, et al.
Published: (2025-07-01)

In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model
by: Roxana Aldea, et al.
Published: (2022-01-01)

Diagnosis, pathomechanisms and therapy of cerebral amyloid angiopathy-related inflammation (CAA-ri)
by: Rebecca M. Seifert, et al.
Published: (2025-04-01)

Cerebral Amyloid Angiopathy: Clinical Presentation, Sequelae and Neuroimaging Features—An Update
by: Stefan Weidauer, et al.
Published: (2025-03-01)

Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years
by: Alexandra Wicker, et al.
Published: (2024-10-01)

On the Therapeutic Use of Monoclonal Antibodies Against Amyloid Plaques in Older Adults with Down Syndrome: A Narrative Review and Perspective
by: Alberto C. S. Costa
Published: (2024-10-01)

Lecanemab for mild Alzheimer disease – is there a way forward?
by: Rajesh R Tampi
Published: (2025-03-01)

Cerebral inflammatory amyloid angiopathy: response to treatment
by: João Roberto Ribeiro Pimenta, et al.
Published: (2025-08-01)

Advancements in Alzheimer's Disease Therapy: The Role of Anti-Amyloid Monoclonal Antibodies - A Literature Review
by: Agnieszka Skoczeń, et al.
Published: (2025-03-01)

Watchful waiting in laryngo‐tracheobronchial amyloid: A case report
by: Dylan Beinart, et al.
Published: (2024-11-01)

The role of neuroinflammation in cerebral amyloid angiopathy
by: Hilde van den Brink, et al.
Published: (2024-12-01)

Amyloid solutions: lecanemab, gantenerumab, and donanemab in the treatment of Alzheimer's disease
by: Taha basit Ameen, et al.
Published: (2025-05-01)

Diagnosis and Treatment of Alzheimer’s Disease: Current Update
by: Younghee Yim, et al.
Published: (2025-01-01)

Monoclonal antibodies against beta-amyloid protein (lecanemab and donanemab) should not be used in the treatment of Alzheimer's disease
by: Ricardo Nitrini, et al.
Published: (2025-05-01)

Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
by: Maksim I. Sulatsky, et al.
Published: (2025-07-01)

The Efficacy of Anti-amyloid Monoclonal Antibodies in Early Alzheimer’s Dementia: A Systematic Review
by: Alyaa Mostafa, et al.
Published: (2025-05-01)

Imaging Findings in Amyloid Arthropathy of the Hip Joints: The Eyes Cannot See What the Mind Does Not Know
by: Nitin P. Ghonge, et al.
Published: (2025-07-01)

Serum amyloid A1 (SAA1) protein in human colostrum
by: George H. Sack Jr, et al.
Published: (2018-03-01)

Targeting Soluble Amyloid Oligomers in Alzheimer’s Disease: A Hypothetical Model Study Comparing Intrathecal Pseudodelivery of mAbs Against Intravenous Administration
by: Manuel Menendez-Gonzalez
Published: (2025-01-01)

Long-term follow-up of retinal amyloid angiopathy in a large Chinese family with hereditary amyloid transthyretin
by: Jiangning Xu, et al.
Published: (2025-04-01)

Comparison of standardized uptake value ratio calculations in amyloid positron emission tomography brain imaging
by: Karin Knesaurek, et al.
Published: (2018-01-01)

Reduced protein solubility – cause or consequence in amyloid disease?
by: Max Lindberg, et al.
Published: (2025-01-01)

Amyloid tumor of the breast
by: Makiko Mori, et al.
Published: (2019-02-01)

Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review
by: Marialuisa Zedde, et al.
Published: (2025-04-01)

Iatrogenic Cerebral Amyloid Angiopathy After Childhood Brain Surgery: Novel Findings of MRI and CT
by: Fumine Tanaka, et al.
Published: (2025-04-01)

Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images
by: Sayed Mehran Sharafi, et al.
Published: (2019-01-01)

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy
by: Marcus Vinicius Pinto, et al.

Cerebral Amyloid Angiopathy Related Inflammation: A Single-Center Case Series Analysis
by: Syed Zahid Ali, et al.
Published: (2025-04-01)

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
by: Shiwani Randhawa, et al.
Published: (2025-04-01)

Evaluating Serum Amyloid A as a Biomarker in Preeclampsia
by: Montadhar K. Sultan, et al.
Published: (2025-03-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-05-01)

Amyloid-β Inhibiting Peptides: An Innovative Strategy for Alzheimer’s Disease Treatment
by: Sajjad Molavipordanjani, et al.
Published: (2023-11-01)

Recent Advances in Amyloids Structural Studies and Thin Film Applications
by: Eugenia Pechkova, et al.
Published: (2025-07-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species
by: Cynthia J. Siebrand, et al.
Published: (2025-05-01)

Perspective: Minimally clinically important “symptomatic” benefit associated with disease modification resulting from anti‐amyloid immunotherapy
by: John Alam, et al.
Published: (2025-01-01)